Healthcare Professionals

Lupin Neurosciences is committed to working with Healthcare Professionals to develop strategies that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.

NaMuscla® is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders.

From SmPC version 1.3.1 – 6.6

Please select your country of residence for locally approved package leaflets:

EMA approved SmPC
PDF download